Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Who Should Consider B12 Injections for Weight Loss
For your patients 1 year of age and older with type 1 diabetes Tresiba (insulin degludec) provides proven A1C reduction with once-daily dosing 1 Efficacy and safety evaluated in adults with T1D Safety study in adults with T1D at increased risk of hypoglycemia Efficacy and safety evaluated in pediatric patients with T1D Safety study in pregnant women with type 1 diabetes As demonstrated in the BEGIN clinical trial program Tresiba offers proven A1C control 1 ADULTS WITH T1D Comparator mean change from baseline Insulin glargine U-100 + insulin aspart Baseline: 7.7% End of trial: 7.3% Reduction: 0.34% Primary endpoint in Study A: A1C reduction from baseline through Week 52
Our Certificate of Analysis (COA) includes HPLC purity analysis, mass spectrometry confirmation, endotoxin testing, and sterility verification
12 Concluding remarks ATs are of interest both as therapeutic agents and as food preservatives
